If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
58
Followers on Owler
Overview
Competitors
Funding
Investments
News & Insights
Cytokinetics Funding History
Since Cytokinetics was founded in 1998, it has participated in 12 rounds of funding. In total Cytokinetics has raised $2.6B. Cytokinetics' last funding round was on May 2026 for a total of $805.0M.
Cytokinetics Funding Rounds
Unlock 9 more funding rounds →
ROUND
FUNDING DATE
AMOUNT
NUMBER OF INVESTORS
INVESTORS
Post-IPO Equity
May 2026
$805M
__
Post-IPO Equity
May 2024
$500M
__
Post-IPO Equity
May 2024
$250M
1
Royalty Pharma plc
Post-IPO Equity
Jan 2022
$50M
1
Royalty Pharma
Post-IPO Equity
Jul 2021
$316.3M
2
H.C. Wainwright & Co.
,
Needham & Company
Cytokinetics Investors
Unlock 7 more investors →
INVESTOR
ROUND
FUNDING DATE
Royalty Pharma plc
Post-IPO Equity
May 2024
Royalty Pharma
Post-IPO Equity
Jan 2022, Feb 2017
H.C. Wainwright & Co.
Post-IPO Equity
Jul 2021
Needham & Company
Post-IPO Equity
Jul 2021
Goldman Sachs & Co. LLC
Post-IPO Equity
Jul 2020
Cytokinetics has 10 investors, including Royalty Pharma plc, Royalty Pharma and H.C. Wainwright & Co.. The latest investment occurred in May 2026.